Physician profile
Robert Hawes
NPI 1295843241
$377,365.79
in general payments reported to CMS, 2019-2025
18 companies · $61K in 2025
The $61K reported for 2025 was more than what 98% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114K · 2020: $37K · 2021: $13K · 2022: $24K · 2023: $62K · 2024: $66K · 2025: $61K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $135K · Travel and Lodging: $38K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,665 · Food and Beverage: $4,171 · Education: $1,999.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $135,245.55 |
| Travel and Lodging | $37,717.45 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,665.00 |
| Food and Beverage | $4,171.10 |
| Education | $1,998.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation | $231,157.40 | 2019-2025 | Evis Exera III Colonovideoscope, Gastrointestinal Videoscope, Evis Eus Endoscopic Ultrasound Center |
| Olympus Corporation of The Americas | $78,656.37 | 2019-2025 | Evis Exera III Duodenovideoscope, Evis Exera III Colonovideoscope, Olympus |
| Olympus America INC. | $58,101.60 | 2019-2025 | Visiglide, Evis Exera II Ultrasound Gastrovideoscope, Evis Eus Endoscopic Ultrasound Center |
| Boston Scientific Corporation | $4,215.13 | 2019-2025 | Exalt Model D, General - Therapies, Acquire |
| Olympus Medical Systems Corporation | $2,507.64 | 2023-2025 | Evis Exera III Colonovideoscope, Gastrointestinal Videoscope |
| Fujifilm Healthcare Americas Corporation | $929.27 | 2021-2023 | Fujifilm |
| Abbvie INC. | $486.35 | 2019-2024 | |
| Omega Medical Imaging, LLC | $273.91 | 2019 | |
| Covidien Lp | $202.63 | 2019 | |
| 3-D Matrix, INC. | $177.22 | 2024 | |
| Creo Medical INC. | $173.44 | 2021 | |
| Asensus Surgical, INC. | $144.21 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $118.15 | 2024 | Terlivaz |
| Medical Device Business Services, INC. | $116.50 | 2019 | |
| Steris Corporation | $44.69 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apollo Endosurgery US INC | $24.72 | 2021 | |
| Conmed Corporation | $21.74 | 2025 | Conmed Hemostasis, Conmed Biliary |
| Cook Medical LLC | $14.82 | 2025 | Echotip Insight |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Hawes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.